—

Boston Scientific Corp (BSX) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Recovery attempt under the 200-day — Trades +3% vs the 50-day and -17.9% vs the 200-day average, 56.6% below the 52-week high and +15.8% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Boston Scientific Corp trades 3.0% above its 50-day and 17.9% below its 200-day moving average. (as of 2026-11-04)

Boston Scientific designs and sells medical devices used in specialist interventional procedures, organised into two segments. MedSurg covers gastrointestinal, urological and neuromodulation tools such as stents, scopes and nerve-ablation systems, while Cardiovascular covers heart devices including the WATCHMAN closure implant, defibrillators, pacemakers and rhythm-monitoring systems.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the BSX overview. Research diary readings, not advice.

Recovery attempt under the 200-day

Trades +3% vs the 50-day and -17.9% vs the 200-day average, 56.6% below the 52-week high and +15.8% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on BSX?

Recovery attempt under the 200-day — Trades +3% vs the 50-day and -17.9% vs the 200-day average, 56.6% below the 52-week high and +15.8% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is BSX above its 50-day and 200-day moving averages?

As of 2026-11-04, Boston Scientific Corp trades +3% above its 50-day and -17.9% below its 200-day average, with the 20-day +3.9% away.

How far is BSX from its 52-week high?

56.6% below the 52-week high and 15.8% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.